GRI MEXC RealStocks
Own real GRI shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 05:59:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
GRI Bio, Inc. (GRI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.84, with a market capitalization of $4.13M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.36 to $64.12. This page covers its latest market performance, valuation, price trends and company information.
$4.13M | |
$1.73 | |
$1.85 | |
$1.71 | |
$1.83 | |
47.86K | |
224.09K | |
-- | |
$64.12 | |
$1.36 | |
-- | |
-- |
GRI Bio, Inc. (GRI) last closed at $1.84 as of 2026-11-13 00:56:00, down 0.55% ($0.01) from the previous close of $1.83.
During the latest regular trading session, GRI traded between $1.71 and $1.85, with a volume of 47.86K shares. The closing price was near the upper end and near the lower end of its 52-week range.
Over the past seven days, GRI Bio, Inc. (GRI) moved from $1.54 to $1.84, representing a gain of 19.16% ($0.29).
The stock traded between $1.36 and $1.97 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 60.65 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.8%
GRI is currently trading at $1.84, placing it 0.8% of the way from its 52-week low of $1.36 to its 52-week high of $64.12. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 5 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for GRI Bio, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Dec 19, 2019 |
| Payment Date | Dec 27, 2019 |
| Dividend Per Share | $0.51129 |
Eligible investors can buy real shares of GRI Bio, Inc. (GRI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to GRI, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between GRI shares and USD.
GRI Shares to USD
1.00 GRI shares = 1.835 USD
Calculations are estimates based on the latest available price and are for reference only.